News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

Veronica Todaro, M.P.H.

Advertisement

Articles by Veronica Todaro, M.P.H.

Patient Engagement in PD Research and Why It Matters

ByVeronica Todaro, M.P.H.
August 19th 2013

When we hear about a new blockbuster drug coming to market, we usually think about a medical treatment.

Advertisement

Latest Updated Articles

  • Patient Engagement in PD Research and Why It Matters
    Patient Engagement in PD Research and Why It Matters

    Published: August 19th 2013 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Drug Repurposing Through AI-Driven In-Silico Clinical Trials

2

CNS and Autoimmune Trials: Growth and Operational Implications

3

ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA

4

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

5

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us